Financial News
Press Releases about Bone Biologics Corp
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Bone Biologics Reports Progress With NB1 Clinical Program
March 01, 2024
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Bone Biologics Announces 1-for-8 Reverse Stock Split
December 18, 2023
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Bone Biologics Provides Scientific Update on NB1 Bone Graft Device
September 26, 2023
From Bone Biologics
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Bone Biologics Effects 1-for-30 Reverse Stock Split
June 06, 2023
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Bone Biologics CEO Issues Letter to Stockholders
October 25, 2022
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20211018005153/en/765880/4/Bone_Biologics_logo.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.